ACME UNITED CORP - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on January 22, 2026, by Acme United Corporation (ACU), a Connecticut corporation. The report discloses the completion of a material asset acquisition on January 15, 2026.
Key Financial Metrics and Transaction Details
The filing details an asset purchase rather than standard periodic financial results. Key transaction metrics include:
- Target: Substantially all assets of SLED Distribution, LLC d/b/a "My Medic" and Rapid Medical, LLC (collectively "Sellers").
- Business Scope: Manufacturing, marketing, and selling of emergency and first aid kits, medical packs, tourniquets, and related products, primarily in the direct-to-consumer channel.
- Total Maximum Purchase Price: $18,700,000.
- Cash Paid at Closing: $14,600,000.
- Contingent Consideration: $1,000,000 (subject to revenue milestones through December 31, 2027).
- Holdback Amount: $3,100,000 (retained as a source of recovery for indemnification claims).
The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the Company or the acquired business for the reporting period.
Material Changes
The primary material change is the expansion of the Company's product portfolio and market presence through the acquisition of the "My Medic" and "Rapid Medical" businesses. The Company assumed specific liabilities related to open purchase orders and specified contracts but explicitly did not assume other liabilities, including pre-closing taxes or liabilities related to excluded assets.
Outlook, Risks, and Contingencies
- Contingent Payments: Future cash outflows of up to $1 million depend on the acquired business achieving specific revenue milestones within the next 12 months.
- Indemnification Holdback: $3.1 million of the purchase price is held back to cover potential indemnification claims regarding breaches of representations, warranties, excluded liabilities, and pre-closing taxes.
- Integration Risks: The agreement includes post-closing obligations for transition services, employee offers, and the assignment of intellectual property and contracts.
- Confidentiality: Portions of the Asset Purchase Agreement (Exhibit 10.1) have been redacted for confidential treatment.
Investor Verification Checklist
- Verify the specific revenue milestones required to trigger the $1 million contingent payment.
- Review the full Asset Purchase Agreement (Exhibit 10.1) for details on the scope of assumed liabilities and indemnification caps.
- Assess the impact of the $14.6 million cash outflow on the Company's current liquidity position.
- Monitor the integration of the direct-to-consumer tactical and trauma product lines into Acme's existing operations.